Abstract:Abstract Objective: Ovarian cancer (OVC) is the fifth leading cause of cancer-related deaths in women and has a significant impact on physical and mental health of women. This study explores the molecular mechanism of miR-636 acting as a tumor suppressor in OVC in vitro and in vivo, and provides new insight into the treatment of OVC.Methods: Protein-protein interaction (PPI) analysis was performed to identify the hub gene in Hedgehog (Hh) pathway. TargetScan database was used to predict the upstream regulatory miRNAs of Gli2 to obtain the target miRNA. qRT-PCR was performed to test the expression of miR-636, while Western blot were conducted to detect the expression of Hh and EMT (epithelial-mesenchymal transition) related genes in OVC cell lines. MTT assay and wound healing assay were used to measure the effect of miR-636 on OVC cell proliferation and migration. Flow cytometry was carried out to examine the effect of miR-636 on cell cycle, and Western blot was used for identification of changes in expression of Hh and EMT related proteins. Dual-luciferase reporter gene assay was implemented to detect the targeted relationship between miR-636 and Gli2. The xenotransplantation model was used to detect the effect of miR-636 on OVC cell proliferation in vivo.Results: PPI interaction analysis found that Gli2 was the hub gene in Hh pathway. Based on TargetScan and GEO databases, Gli2 was found to be targeted regulated by the upstream miR-636. In vitro experiments discovered that miR-636 was significantly lowly expressed in OVC cell lines. Overexpressing miR-636 significantly inhibited HO-8910PM cell proliferation and migration abilities as well as induced cell cycle arrest in G0/G1 phase, while the inhibition of miR-636 promoted cell proliferation and migration abilities. Dual-luciferase reporter gene assay revealed that Gli2 was a target gene of miR-636. Besides, overexpressing miR-636 decreased protein expression of Gli2, while the inhibition of miR-636 increased protein expression of Gli2. Furthermore, the overexpression and inhibition of miR-636 both affected the expression of proteins related to Hh signaling pathway and EMT. Rescue experiments verified that overexpression of Gli2 reversed the inhibitory effect of miR-636 on HO-8910PM cell proliferation and migration abilities, and attenuated the blocking effect of miR-636 on HO-8910PM cell cycle. The xenotransplantation model suggested that miR-636 inhibited cell growth of OVC by decreasing Gli2 expression. Besides, overexpressing Gli2 potentiated the EMT process in OVC via decreasing E-cadherin protein expression and increasing Vimentin protein expression, and it reversed the inhibitory effect of miR-636 on OVC cell proliferation and migration abilities in vivo.Conclusion: miR-636 inhibits the Hh pathway activation via targeted binding to Gli2, thus inhibiting EMT, cell proliferation and migration in OVC.

MicroRNA-200c suppresses epithelial-mesenchymal transition of ovarian cancer by targeting cofilin-2

MicroRNA-200c overexpression inhibits tumorigenicity and metastasis of CD117+CD44+ ovarian cancer stem cells by regulating epithelial-mesenchymal transition

miR-200c modulates ovarian cancer cell metastasis potential by targeting zinc finger E-box-binding homeobox 2 (ZEB2) expression

miR‐200c overexpression inhibits the invasion and tumorigenicity of epithelial ovarian cancer cells by suppressing lncRNA HOTAIR in mice

MicroRNA-200b Suppresses Cell Invasion and Metastasis by Inhibiting the Epithelial-Mesenchymal Transition in Cervical Carcinoma.

MicroRNA-200a inhibits CD133/1+ ovarian cancer stem cells migration and invasion by targeting E-cadherin repressor ZEB2.

MicroRNA-140-5p Targets Insulin Like Growth Factor 2 Mrna Binding Protein 1 (IGF2BP1) to Suppress Cervical Cancer Growth and Metastasis.

miR-372 inhibits EMT, invasion and migration of ovarian cancer cells and the possible mechanism

MicroRNA-200a Inhibits Epithelial-Mesenchymal Transition in Human Hepatocellular Carcinoma Cell Line.

Overexpression of miR-200s inhibits proliferation and invasion while increasing apoptosis in murine ovarian cancer cells

COUP‑TFII Promotes Epithelial‑mesenchymal Transition by Inhibiting Mir‑34a Expression in Colorectal Cancer.

Upregulation of miR-874-3p and miR-874-5p inhibits epithelial ovarian cancer malignancy via SIK2.

MicroRNA-424 Inhibits Cell Migration, Invasion, and Epithelial Mesenchymal Transition by Downregulating Doublecortin-Like Kinase 1 in Ovarian Clear Cell Carcinoma.

MiR‐506 Inhibits Multiple Targets in the Epithelial‐to‐mesenchymal Transition Network and is Associated with Good Prognosis in Epithelial Ovarian Cancer

MiR-628-5p Decreases the Tumorigenicity of Epithelial Ovarian Cancer Cells by Targeting at FGFR2.

MicroRNA-219-5p Inhibits the Proliferation, Migration, and Invasion of Epithelial Ovarian Cancer Cells by Targeting the Twist/Wnt/β-catenin Signaling Pathway.

MicroRNA-141 inhibits epithelial-mesenchymal transition, and ovarian cancer cell migration and invasion

MicroRNA-200a Promotes Proliferation and Invasion of Ovarian Cancer Cells by Targeting PTEN

miR-636 Inhibits EMT, Cell Proliferation and Cell Cycle of Ovarian Cancer by Directly Targeting the Transcription Factor Gli2 of Hedgehog Pathway

Exosomal Mir-34B Inhibits Proliferation and the Epithelial-Mesenchymal Transition by Targeting Notch2 in Ovarian Cancer

MicroRNA-200c Prevents Progress of Cutaneous Squamous Cell Carcinoma by Targeting Tyrosine-Protein Kinase Fyn (FYN)